Valve choice - Shaping index procedures and lifetime patient management

Sponsored by Boston Scientific

Anchorperson: T. Rudolph

Spokesperson: W. K. Kim

Summary

This session addresses recent advancements and ongoing challenges in transcatheter aortic valve implantation (TAVI), with a particular focus on valve selection during index procedures. Presentations include data from the Accurate IDE trial, highlighting the prognostic implications of valve underexpansion. A clinical case involving an 80-year-old patient with severe aortic stenosis and multiple comorbidities illustrates the importance of personalized procedural planning, particularly in terms of vascular access and valve positioning. The session also emphasizes the value of lifetime patient management strategies, including coronary access and the feasibility of redo TAVI, supported by simulation.

Learning Objectives

To understand how index procedure optimisation will define long-term clinical outcomes
To review latest clinical data on a novel self-expanding device and how it can guide index procedure decision making
To learn how to plan for lifetime patient management including coronary access and redo TAVI supported by simulation